Diltiazem hydrochloride - Drug Shortage Information

Public shortage context is available across 14 visible exact NDC pages for this generic family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

Family summary

Current and historical shortage references are available across related Diltiazem hydrochloride presentations from multiple manufacturers.

  • 7 current shortage context pages.
  • 7 historical shortage context pages.
  • 6 manufacturers represented.

Related research paths

Common brands and presentations in this family

These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

Exact NDC product pages in this shortage family

Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug NameNDC 11ManufacturerShortage Context
diltiazem hydrochloride 5 mg / mL Injection 5 mL
NDC 55150-0425-10 | 10 Vial, Single-Dose | Eugia US LLC
55150-0425-10Eugia US LLCCurrent shortage context
diltiazem hydrochloride 5 mg / mL Injection 10 mL
NDC 55150-0426-10 | 10 Vial, Single-Dose | Eugia US LLC
55150-0426-10Eugia US LLCCurrent shortage context
diltiazem hydrochloride 5 mg / mL Injection 25 mL
NDC 55150-0427-10 | 10 Vial, Single-Dose | Eugia US LLC
55150-0427-10Eugia US LLCCurrent shortage context
diltiazem hydrochloride 5 mg / mL Injection 10 mL
NDC 25021-0319-10 | 10 Vial | Sagent Pharmaceuticals
25021-0319-10Sagent PharmaceuticalsCurrent shortage context
Diltiazem Hydrochloride 5 mg / mL Injection 10 mL
NDC 00641-6014-10 | 10 Vial | Hikma Pharmaceuticals USA Inc.
00641-6014-10Hikma Pharmaceuticals USA Inc.Current shortage context
Diltiazem Hydrochloride 5 mg / mL Injection 25 mL
NDC 00641-6015-10 | 10 Vial | Hikma Pharmaceuticals USA Inc.
00641-6015-10Hikma Pharmaceuticals USA Inc.Current shortage context
Diltiazem Hydrochloride 100 mg / 1 Injection 10 Vial, Patent Delivery SystemPRN Watchlist
NDC 00409-4350-03 | 10 Vial, Patent Delivery System | Hospira, Inc.
00409-4350-03Hospira, Inc.Current shortage context
diltiazem hydrochloride 90 mg / 1 Capsule 100 Blister Pack
NDC 51079-0925-20 | 100 Blister Pack | Mylan Institutional Inc.
51079-0925-20Mylan Institutional Inc.Historical shortage context
diltiazem hydrochloride 90 mg / 1 Capsule 100 Capsule, Extended Release
NDC 00378-6090-01 | 100 Capsule, Extended Release | Mylan Pharmaceuticals Inc.
00378-6090-01Mylan Pharmaceuticals Inc.Historical shortage context
diltiazem hydrochloride 5 mg / mL Injection 5 mL
NDC 25021-0319-05 | 10 Vial | Sagent Pharmaceuticals
25021-0319-05Sagent PharmaceuticalsHistorical shortage context
diltiazem hydrochloride 5 mg / mL Injection 25 mL
NDC 25021-0319-25 | 10 Vial | Sagent Pharmaceuticals
25021-0319-25Sagent PharmaceuticalsHistorical shortage context
Diltiazem Hydrochloride 5 mg / mL Injection 5 mL
NDC 00641-6013-10 | 10 Vial | Hikma Pharmaceuticals USA Inc.
00641-6013-10Hikma Pharmaceuticals USA Inc.Historical shortage context
Diltiazem Hydrochloride 5 mg / mL Injection 5 mL
NDC 00641-9217-10 | 10 Vial | Hikma Pharmaceuticals USA Inc.
00641-9217-10Hikma Pharmaceuticals USA Inc.Historical shortage context
Diltiazem Hydrochloride 5 mg / mL Injection 25 mL
NDC 00641-9219-10 | 10 Vial | Hikma Pharmaceuticals USA Inc.
00641-9219-10Hikma Pharmaceuticals USA Inc.Historical shortage context

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.